1. Short title This Act may be cited as the Overdose Reversal Medication Act or the ORM Act . 2. Opioid overdose reversal drug standard (a) Interim Final Standard (1) In general Not later than 1 year after the date of enactment of this Act, the Secretary of Labor shall issue an interim final standard on workplace availability of an opioid overdose reversal drug or device— (A) to require all employers to possess an opioid overdose reversal drug or device on site, where the required number of doses of such drug or device required is determined on the basis of the number of employees of the employer on site, type of occupation, and an assessment of potential use; (B) that establishes guidelines for training on— (i) identifying signs and symptoms indicating that usage of an opioid overdose drug or device is necessary; and (ii) how to administer such opioid overdose reversal drug or device; and (C) that provides for a period as determined appropriate by the Secretary, not to exceed 1 year, during which the Secretary shall prioritize technical assistance and advice consistent with section 21(d) of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 670(d) ) to employers subject to the standard with respect to compliance with the standard. (2) Effective date of interim standard The interim final standard shall— (A) take effect on a date that is not later than 30 days after issuance; (B) shall have the same legal effect as an occupational safety and health standard as defined by section 3 of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 652 )